Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Crane

Showing results (211-220 of 301) with videos related to

Pageof 31
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancerTse-Kuan Yu, Priya R Bhosale, Christopher H Crane, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombusEmma B Holliday, Randa Tao, Zachary Brownlee, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|September 19, 2001
Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancerC H Crane, N A Janjan, D B Evans, et al.
NPJ Precision Oncology|October 31, 2018
Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapyTheodore S Hong, Clemens Grassberger, Beow Y Yeap, et al.
American Journal of Clinical Oncology|June 7, 2006
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancerPrajnan Das, John M Skibber, Miguel A Rodriguez-Bigas, et al.
JAMA Oncology|July 9, 2017
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical TrialMohan Suntharalingam, Kathryn Winter, David Ilson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancerC H Crane, N A Janjan, J L Abbruzzese, et al.
Annals of Surgical Oncology|March 22, 2001
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival durationT M Breslin, K R Hess, D B Harbison, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2013
Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trialPrajnan Das, Cathy Eng, Miguel A Rodriguez-Bigas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineDavendra P S Sohal, Pamela B Mangu, Alok A Khorana, et al.
Pageof 31

Showing results (211-220 of 301) with videos related to

Sort By:
Pageof 31
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancerTse-Kuan Yu, Priya R Bhosale, Christopher H Crane, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombusEmma B Holliday, Randa Tao, Zachary Brownlee, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|September 19, 2001
Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancerC H Crane, N A Janjan, D B Evans, et al.
NPJ Precision Oncology|October 31, 2018
Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapyTheodore S Hong, Clemens Grassberger, Beow Y Yeap, et al.
American Journal of Clinical Oncology|June 7, 2006
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancerPrajnan Das, John M Skibber, Miguel A Rodriguez-Bigas, et al.
JAMA Oncology|July 9, 2017
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical TrialMohan Suntharalingam, Kathryn Winter, David Ilson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancerC H Crane, N A Janjan, J L Abbruzzese, et al.
Annals of Surgical Oncology|March 22, 2001
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival durationT M Breslin, K R Hess, D B Harbison, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2013
Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trialPrajnan Das, Cathy Eng, Miguel A Rodriguez-Bigas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineDavendra P S Sohal, Pamela B Mangu, Alok A Khorana, et al.
Pageof 31